Paediatric abdominal tuberculosis in developed countries: case series and literature review

Megan Delisle1, Jade Seguin2, David Zeilinski3

  • 1McGill University, Montreal, Canada.

Insights

Paediatric abdominal tuberculosis (TB) in developed countries often affects immigrant and aboriginal children. Diagnosis relies on clinical signs, imaging, and biopsies, guiding conservative management.

Area of Science:

  • Pediatric infectious diseases
  • Gastroenterology
  • Public health

Background:

  • Paediatric abdominal tuberculosis (TB) is uncommon in developed countries.
  • Understanding its presentation, diagnosis, and management is crucial for timely intervention.

Observation:

  • A case series and literature review identified common clinical features including abdominal pain, fever, and weight loss.
  • Imaging revealed gastrointestinal TB with colonic wall irregularity and peritoneal TB with ascites.
  • Tuberculin skin tests were positive in 90% of cases.

Findings:

  • Diagnosis was aided by imaging (ultrasound/CT) and tissue sampling via aspiration or biopsy.
  • Surgical intervention was performed in 76% of cases, often for diagnostic purposes.
  • Cultures confirmed TB in 73% of patients.

Implications:

  • Clinical presentation combined with imaging-guided biopsies can support a conservative management approach for paediatric abdominal TB.
  • Early diagnosis and appropriate management are essential to improve outcomes in affected children.
Abstract

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
699
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
827
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704